Citations 2
A Phase 3, 2-part, Open-label, Multicenter Study to Evaluate the Safety, and Efficacy of Liposomal Treprostinil Inhalation Suspension (l606) in Subjects With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung
Habib, N. , Jaramillo, R. Restrepo, Shapiro, Shelley, Galloway, Ashley L. , Kan, Peter , Saggar, Rajeev, Shapiro, Shelley, Burger, Charles D. , Patel, Shardool A. , Kan, P.
D105. BALBOA PARK EXPLORERS: TRANSLATIONAL SCIENCE AND EPIDEMIOLOGY IN PH | April 30, 2024 | Volume: No volume available | Issue: No issue available | Pages: A7368-A7368
Expert Consensus on the Screening, Treatment, and Management of Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD), and the Potential Future Role of Anti-fibrotics[asterisk] in a Treatment Paradigm for SSc-ILD: A Delphi Consens
Rahaghi, Franck , Strek, Mary E. , Southern, Brian D. , Saggar, Rajeev, Hsu, Vivien , Steen, Virginia , Domsic, Robyn T. , Rosas, Iván O. , Kaner, R.J. , Bhatt, Navin, Flaherty, Kevin R. , Patel, N. , Shlobin, Oksana A. , Castelino, Flavia V. , Kahaleh, Bashar , Moua, Teng , Volkmann, Elizabeth R. , Mayes, Maureen D. , Silver, Richard M. , Gupta, Nishant , Martínez, Fernando J. , Morrow, Lee E. , Bernstein, Elana J. , Chung, L., Khanna, Dinesh
C101. NON-IDIOPATHIC INTERSTITIAL PNEUMONIA NATURAL HISTORY AND PROGNOSIS AND ILD THERAPY | August 26, 2019 | Volume: No volume available | Issue: No issue available | Pages: A7445-A7445